Home > PE Ratio > KWALITY PHARMACEUTICALS

KWALITY PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of KWALITY PHARMACEUTICALS is 44.50.

Share Price ₹509.1May 17,2024
Market Cap ₹529.5 Cr
Earnings-TTM₹11.9 CrTTM-Consolidated Results
Price/Earnings44.50xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for KWALITY PHARMACEUTICALS
Please provide your vote to see the results
KWALITY PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of KWALITY PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of KWALITY PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹529.5 Cr] as on May 17,2024

(/) Earnings [ ₹11.9 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 44.50x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for KWALITY PHARMACEUTICALS , the investors are currently willing to pay 44.50 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of KWALITY PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of KWALITY PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of KWALITY PHARMACEUTICALS


PE Ratio Performance Analysis for KWALITY PHARMACEUTICALS

- KWALITY PHARMACEUTICALS 's latest p/e ratio is 44.50x.

- KWALITY PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 6.72x.

- KWALITY PHARMACEUTICALS 's operated at median p/e ratio of 5.02x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, KWALITY PHARMACEUTICALS 's p/e ratio peaked in Mar2023 at 16.47x.

- KWALITY PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 3.19x.


How does KWALITY PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
KWALITY PHARMACEUTICALS 11.9044.50529.5
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6340.84367,470.0
CIPLA LTD4,155.3127.19112,990.0
DR REDDYS LABORATORIES LTD5,563.2017.3996,742.1
ZYDUS LIFESCIENCES LTD3,831.4027.63105,846.0
DIVIS LABORATORIES LTD1,382.9775.09103,849.0
MANKIND PHARMA LTD1,926.5543.5483,873.0
TORRENT PHARMACEUTICALS LTD1,494.0061.1391,321.0
LUPIN LTD1,935.5738.9175,312.7
AUROBINDO PHARMA LTD2,777.8924.5568,194.5
ABBOTT INDIA LTD1,201.2246.8656,289.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs KWALITY PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 17.39x
Max industry PE 75.09x
Median industry PE 40.84x
Average industry PE 40.69x



You may also like the below Video Courses